Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Royan Institute

Iran

Country: Iran

Ownership: Private

Established: 1991-01-01

Employees: -

Market Cap: -

Website: http://www.royaninstitute.org

Clinical Trials

Mesenchymal Stem Cells Transplantation in Newly Diagnosed Type-1 Diabetes Patients

Phase 1

Conditions: Diabetes Mellitus, Insulin-Dependent
Diabetes Mellitus
Diabetes Mellitus, Type 1

Interventions: Biological: Intravenous Injection of autologous mesenchymal stem cells
Other: Intravenous injection of placebo

First Posted Date: 2019-09-06

Last Posted Date: 2019-09-06

Lead Sponsor: Royan Institute

Target Recruit Count: 20

Registration Number: NCT04078308

Locations: 🇮🇷
Royan Institute, Tehran, Iran, Islamic Republic of

Intrauterine Flushing With Follicular Fluid Plus Granulosa Cells

Phase 3

Completed

Conditions: Embryo Implantation
Granulosa Cell
Follicular Fluid

Interventions: Biological: Intrauterine flushing of follicular fluid with granulosa cells

First Posted Date: 2019-09-04

Last Posted Date: 2023-03-14

Lead Sponsor: Royan Institute

Target Recruit Count: 140

Registration Number: NCT04077970

Locations: 🇮🇷
Royan Institute, Tehran, Iran, Islamic Republic of

Acupuncture for Treatment of Patients With Poor Ovarian Response

Not Applicable

Completed

Conditions: Poor Ovarian Response
Accupuncture

Interventions: Other: Accupuncture

First Posted Date: 2019-07-10

Last Posted Date: 2023-06-15

Lead Sponsor: Royan Institute

Target Recruit Count: 43

Registration Number: NCT04013984

Locations: 🇮🇷
Royan Institute, Tehran, Iran, Islamic Republic of

Luteal Phase Support During Frozen Embryo Transfer Cycle

Phase 3

Completed

Conditions: Infertility, Female
Frozen Embryo Transfer

Interventions: Drug: Strogen

First Posted Date: 2019-07-09

Last Posted Date: 2019-07-09

Lead Sponsor: Royan Institute

Target Recruit Count: 60

Registration Number: NCT04013438

Locations: 🇮🇷
Royan Institute, Tehran, Iran, Islamic Republic of

Platelet Rich Plasma and Recurrent Implantation Failure

Not Applicable

Completed

Conditions: Recurrent Implantation Failure

Interventions: Other: Intra uterine infusion of platelet rich plasma

First Posted Date: 2019-06-25

Last Posted Date: 2024-01-03

Lead Sponsor: Royan Institute

Target Recruit Count: 80

Registration Number: NCT03996837

Locations: 🇮🇷
Royan Institute, Tehran, Iran, Islamic Republic of

The Four Methods of Ovarian Stimulation in Patients With Polycystic Ovarian Syndrome

Not Applicable

Completed

Conditions: Ovarian Hyperstimulation Syndrome
Polycystic Ovary Syndrome

Interventions: Other: Minimal ovarian stimulation

First Posted Date: 2019-03-15

Last Posted Date: 2021-04-20

Lead Sponsor: Royan Institute

Target Recruit Count: 120

Registration Number: NCT03876145

Locations: 🇮🇷
Royan Institute, Tehran, Iran, Islamic Republic of

NAC Effect on Hox Genes Expressions in RIF

Phase 3

Completed

Conditions: Female Infertility

Interventions: Drug: N-acetyl cysteine
Drug: Placebos

First Posted Date: 2019-03-05

Last Posted Date: 2019-03-05

Lead Sponsor: Royan Institute

Target Recruit Count: 40

Registration Number: NCT03862586

Sildenafil and Outcome of IVF/ICSI Cycles

Phase 1

Conditions: Infertility, Female

Interventions: Drug: Sildenafil vaginal suppositories
Other: vaginal placebo

First Posted Date: 2017-06-20

Last Posted Date: 2017-06-20

Lead Sponsor: Royan Institute

Target Recruit Count: 60

Registration Number: NCT03192709

Locations: 🇮🇷
Royan Institute, Tehrān, Iran, Islamic Republic of

GnRh Antagonist Protocol With Delayed Start Stimulation in Patients With Poor Ovarian Response

Not Applicable

Completed

Conditions: Infertility, Female

Interventions: Procedure: delayed start
Procedure: Conventional

First Posted Date: 2017-05-01

Last Posted Date: 2023-02-08

Lead Sponsor: Royan Institute

Target Recruit Count: 120

Registration Number: NCT03134690

Locations: 🇮🇷
Royan Institute, Tehran, Iran, Islamic Republic of

The Effect of Simvastatin on Uterine Leiomyoma Development and Growth in Infertile Women

Phase 3

Conditions: Infertility

Interventions: Drug: oral drug and vaginal placebo
Drug: Vaginal placebo+ oral placebo
Drug: oral drug and oral placebo

First Posted Date: 2017-04-28

Last Posted Date: 2020-10-06

Lead Sponsor: Royan Institute

Target Recruit Count: 60

Registration Number: NCT03134157

Locations: 🇮🇷
Royan Institute, Tehrān, Iran, Islamic Republic of

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy